Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP study

International Journal of Cardiology

Volumn 136, Issue 1, 2009, Pages 56-63

  Otero Raviña, Fernando ^a   Grigorian Shamagian, Lilian ^b   Fransi Galiana, Luis ^c   Názara Otero, Carlos ^d   Fernández Villaverde, José Ma ^d   del Álamo Alonso, Alberto ^e   Nieto Pol, Enrique ^f   de Santiago Boullón, Miguel ^d   López Rodríguez, Isidro ^d   Cardona Vidal, José Ma ^g   Varela Román, Alfonso ^b   González Juanatey, José R ^b  

^a SERGAS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c CS Rúa Cuba   (Spain)

^d CS Casa do Mar ^*  (Spain)

^e Centro de Salud Novoa Santos   (Spain)

^f Ambulatorio Portugal   (Spain)

^g CS Ventorrillo   (Spain)

Author keywords

Heart failure; Primary care; Prognosis

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DEATH; HEART EDEMA; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; OUTPATIENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SPAIN; STROKE; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MORBIDITY; PATIENT ADMISSION; PROSPECTIVE STUDIES; SPAIN; SURVIVAL RATE;

EID: 67649862213     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.025     Document Type: Article

References (31)

1. Cleland J.G.F., Khand A., and Clark A.L. The heart failure epidemic: exactly how big is it?. Eur Heart J 22 (2001) 623-626
2. Rodríguez-Artalejo F., Banegas Banegas J.R., and Guallar-Castillón P. Epidemiología de la insuficiencia cardíaca. Rev Esp Cardiol 57 (2004) 163-170
3. Vinson J.M., Rich M.W., Sperry J.C., et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 38 (1990) 1290-1295
4. Krumholz H.M., Chen Y.T., Wang Y., et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 139 (2000) 72-77
5. Galofré N., San Vicente L., González J.A., et al. Morbimortalidad de los pacientes ingresados por insuficiencia cardíaca. Factores predictores de reingreso. Med Clin 124 (2005) 285-290
6. Atienza F., Anguita M., Martínez-Alzamora N., et al. Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail 6 (2004) 643-652
7. Duaso E., Díez-Caballero M., and Formiga F. Abordaje de la insuficiencia cardíaca en ancianos: una visión desde la atención primaria. Rev Esp Cardiol 59 (2006) 290-291
8. Galbreath A.D., Krasuski R.A., Smith B., et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 110 (2004) 3518-3526
9. Kimmelstiel C., Levine D., Perry K., et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation 110 (2004) 1450-1455
10. Poole-Wilson P.A., Swedberg K., Cleland J.G.F., et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 362 (2003) 7-13
11. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
12. Komajda M., Lapuerta P., Hermans N., et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 26 (2005) 1653-1659
13. Permanyer Miralda G., Soriano N., Brotons C., et al. Características basales y determinantes de la evolución en pacientes ingresados por insuficiencia cardíaca en un hospital general. Rev Esp Cardiol 55 (2002) 571-578
14. Varela Román A., González-Juanatey J.R., Basante P., et al. Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction. Heart 88 (2002) 249-254
15. Lee D.S., Austin P.C., Rouleau J.L., et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 290 (2003) 2581-2587
16. Otero-Raviña F., Grigorian-Shamagian L., Fransi L., et al. Estudio Gallego de Insuficiencia Cardíaca en Atención Primaria (Estudio GALICAP). Rev Esp Cardiol 60 (2007) 373-383
17. Cifkova R., Erdine S., Fagard R., et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21 (2003) 1779-1786
18. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 (2004) 1953-1959
19. Anguita Sanchez M. Investigadores del Registro BADAPIC. Características clínicas, tratamiento y morbimortalidad a corto plazo de pacientes con insuficiencia cardíaca controlados en consultas específicas de insuficiencia cardíaca. Resultados del Regiatro BADAPIC. Rev Esp Cardiol 57 (2004) 1159-1169
20. Cleland J.G., Swerberg K., Follath F., et al. The EuroHeart Failure Survey Programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
21. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
22. Solomon S.D., Anavekar N., Skali H., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (2005) 3738-3744
23. Pitt B., Remme W., Zannad F., et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348 (2003) 1309-1321
24. Granger B.B., Swedberg K., Ekman I., et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 366 (2005) 2005-2011
25. Varela-Román A., Grigorian-Shamagian L., Barge E., et al. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart 91 (2005) 489-494
26. Grigorian Shamagian L., Varela Román A., García-Acuña J.M., et al. Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function. Heart 92 (2006) 780-784
27. Komajda M. Prevalence of anaemia in patients with chronic heart failure and their clinical characteristics. J Card Fail 10 (2004) S1-S4
28. Westenbrink B.D., Visser F.W., Voors A.A., et al. Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well. Eur Heart J 28 (2007) 166-171
29. Lenzen M.J., Scholte op Reimer W.J., Boersma E., et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004) 1214-1220
30. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
31. Flather M.D., Shibata M.C., Coats A.J., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225